𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hormone replacement therapy and risk of epithelial ovarian cancer

✍ Scribed by Purdie, D M; Bain, C J; Siskind, V; Russell, P; Hacker, N F; Ward, B G; Quinn, M A; Green, A C

Book ID
110002511
Publisher
Nature Publishing Group
Year
1999
Tongue
English
Weight
67 KB
Volume
81
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Estrogen replacement therapy and ovarian
Estrogen replacement therapy and ovarian cancer risk
✍ Fabio Parazzini; Carlo La Vecchia; Eva Negri; Antonella Villa πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 144 KB πŸ‘ 1 views
Use of hormone replacement therapy befor
Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival
✍ Chantal Mascarenhas; Mats Lambe; Rino Bellocco; Kjell Bergfeldt; Tomas Riman; In πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 190 KB πŸ‘ 1 views

## Abstract Use of hormone replacement therapy (HRT) has been hypothesized to affect survival of epithelial ovarian cancer (EOC). We studied 5‐year survival in patients with invasive EOC and borderline ovarian tumors (BOT) according to HRT use before and after diagnosis in a prospective nation‐wide

Hormone replacement therapy and lung can
Hormone replacement therapy and lung cancer risk in Chinese
✍ Kuan-Yu Chen; Chin-Fu Hsiao; Gee-Chen Chang; Yin-Huang Tsai; Wu-Chou Su; Reury-P πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. The association between hormone replacement therapy (HRT) and a reduced lung cancer risk has been reported in previous studies. There is a high female to male ratio in Chinese lung cancer patients, and female patients have different clinicopathological characteristics co

Risk of cancer in women receiving hormon
Risk of cancer in women receiving hormone replacement therapy
✍ Hans-Olov Adami; Ingemar Persson; Robert Hoover; Catharine Schairer; Leif Bergkv πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 French βš– 828 KB

Cancer risk following treatment with non-contraceptive estrogens was studied in a population-based cohort of 23,244 women. Complete follow-up for an average of 6.7 years revealed 1,087 incident cancers versus 962.5 expected (relative risk/RR/ = 1.13; 95% confidence interval 1.10-1.20). We confirmed